Racial/ethnic disparities in socioeconomic status, diagnosis, treatment and survival among Medicare-insured men and women with head and neck cancer

Journal of Health Care for the Poor and Underserved

Volumn 21, Issue 3, 2010, Pages 913-930

  Du, Xianglin L ^a,b   Liu, Chih Chin ^a  

^a Health Science Center (UT HSC)   (United States)

^b UT HSC ^*  (United States)

Author keywords

Head and neck cancer; Racial disparity; Socioeconomic status; Survival; Treatment

Indexed keywords

AGED; ARTICLE; CANCER REGISTRY; ETHNOLOGY; FEMALE; HEAD AND NECK TUMOR; HEALTH CARE DISPARITY; HUMAN; INSURANCE; MALE; MEDICARE; MORTALITY; RACE; RISK FACTOR; SOCIAL CLASS; STATISTICS; SURVIVAL; TREATMENT OUTCOME; UNITED STATES;

AGED; AGED, 80 AND OVER; CONTINENTAL POPULATION GROUPS; FEMALE; HEAD AND NECK NEOPLASMS; HEALTHCARE DISPARITIES; HUMANS; INSURANCE COVERAGE; MALE; MEDICARE; RISK FACTORS; SEER PROGRAM; SOCIAL CLASS; SURVIVAL; TREATMENT OUTCOME; UNITED STATES;

EID: 77955940252     PISSN: 10492089     EISSN: 15486869     Source Type: Journal    
DOI: 10.1353/hpu.0.0331     Document Type: Article

References (43)

1. National Cancer Institute. SEER stat fact sheets: oral cavity and pharynx. Bethesda, MD: National Cancer Institute, 2009. Available at: http://seer.cancer.gov/statfacts/html/oralcav.html.
2. American Cancer Society. Cancer facts and fgures, 2009. Atlanta, GA: American Cancer Society, 2009. Available at: http://www.cancer.org/downloads/ STT/500809webpdf.
3. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer. 2004 Jul; 101(1):3-27.
4. Haynes MA, Smedley BD. The unequal burden of cancer: an assessment of NIH research and programs for ethnic minorities and the medically underserved. # Washington, DC: National Academy Press, 1999.
5. Clegg LX, Li F P, Hankey BF, et al. Cancer survival among U. S. Whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) program population-based study. Arch Intern Med. 2002 Sep; 162(17):1985-93.
6. Ward E, Jemal A, Cokkinides V, et al. Cancer Disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004 Mar-Apr; 54(2):78-93.
7. Newman LA, Griffith KA, Jatoi I, et al. Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol. 2006 Mar; 24(9):1342-9.
8. Du XL, Meyer TE, Franzini, et al. Meta-analysis of racial disparities in survival in association with socioeconomic status among men and women with colon cancer. Cancer. 2007 Jun; 109(11):2161-70.
9. Evans S, Metcalfe C, Ibrahim F, et al. Investigating Black-White differences in prostate cancer prognosis: a systematic review and meta-analysis. Int J Cancer. 2008 Jul; 123(2):430-5.
10. Bach PB, Schrag D, Brawley OW, et al. Survival of blacks and whites afer a cancer diagnosis. JAMA. 2002 Apr; 287(16):2106-13.
11. Bradley CJ, Given C W, Roberts C, et al. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002 Apr; 94(7):490-6.
12. Tammemagi CM. Racial/ethnic disparities in breast and gynecologic cancer treatment and outcomes. Curr Opin Obstet Gynecol. 2007 Feb; 19(1):31-6.
13. Howard G, Anderson RT, Russell G, et al. Race, socioeconomic status, and causespecifc mortality. Ann Epidemiol. 2000 May; 10(4):214-23.
14. Du XL, Fang S, Coker AL, et al. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer. 2006 Mar; 106(6):1276-85.
15. Coker AL, Du XL, Fang S, et al. Socioeconomic status and cervical cancer survival among older women: findings from the SEER-Medicare linked data cohorts. Gynecol Oncol. 2006 Aug; 102(2):278-84.
16. Du XL, Sun CC, Milam MR, et al. Ethnic differences in socioeconomic status, diagnosis, treatment and survival among older women with epithelial ovarian cancer. Int J Gynecol Cancer. 2008 Jul-Aug; 18(4):660-9.
17. Wang M, Burau KD, Fang S, et al. Ethnic variations in diagnosis, treatment, socioeconomic status and survival in a large population-based cohort of elderly patients with non-Hodgkin's lymphoma. Cancer. 2008 Dec; 113(11):3231-41.
18. Goodwin WJ, Tomas GR, Parker DF, et al. Unequal burden of head and neck cancer in the United States. Head Neck. 2008 Mar; 30(3):358-71.
19. Morse DE, Kerr AR. Disparities in oral and pharyngeal cancer incidence, mortality and survival among black and white Americans. J Am Dent Assoc. 2006 Feb; 137(2):203-12.
20. Moore RJ, Doherty DA, Do KA, et al. Racial disparity in survival of patients with squamous cell carcinoma of the oral cavity and pharynx. Ethn Health. 2001 Aug-Nov; 6 (3-4): 165-77.
21. Shavers VL, Harlan LC, Winn D, et al. Racial/ethnic patterns of care for cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands. Cancer Metastasis Rev. 2003 Mar; 22(1):25-38.
22. Shiboski CH, Schmidt BL, Jordan RC. Racial disparity in stage at diagnosis and survival among adults with oral cancer in the U. S. Community Dent Oral Epidemiol. 2007 Jun; 35(3):233-40.
23. Molina MA, Cheung MC, Perez EA, et al. African American and poor patients have a dramatically worse prognosis for head and neck cancer: an examination of 20, 915 patients. Cancer. 2008 Nov; 113(10):2797-806.
24. National Cancer Institute. Surveillance epidemiology and end results (SEER): providing information on cancer statistics to help reduce the burden of this disease on the U. S. population. Bethesda, MD: National Cancer Institute, 2005. Available at: http://seer.cancer.gov/about/SEER-brochurepdf.
25. Potosky AL, Riley GF, Lubitz JD, et al. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care. 1993 Aug; 31(8):732-48.
26. Warren JL, Klabunde CN, Schrag D, et al. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002 Aug; 40 (8 Suppl): IV-3-18.
27. Smith GL, Smith BD, Buchholz TA, et al. Cerebrovascular disease risk in older head and neck cancer patients afer radiotherapy. J Clin Oncol. 2008 Nov; 26(31):5119-25.
28. Du XL, Freeman JL, Goodwin JS. Information on radiation treatment in patients with breast cancer: the advantages of the linked medicare and SEER data. Surveillance, Epidemiology and End Results. J Clin Epidemiol. 1999 May; 52(5):463-70.
29. U. S. Public Health Services, Health Care Financing Administration. International classifcation of diseases, 9th Revision, clinical modifcation (5th ed.). Washington, DC: U. S. Public Health Services/Health Care Financing Administration, 1996.
30. American Medical Association. Current procedural terminology. Chicago, IL: American Medical Association, 2000. Available at: http://www.ama-assn.org/ ama/pub/physician-resources/solutions-managing-your-practice/ coding-billing-insurance/cpt.shtml.
31. Center for Medicare and Medicaid Services. Health care common procedure coding system: level 11 coding procedures. Washington, DC: Center for Medicare and Medicaid Services, 2009. Available at: http://www.cms.gov/MedHCPCSGenInfo/ Downloads/LevelIICodingProcedurespdf.
32. Du X, Goodwin JS. Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data. J Clin Oncol. 2001 Mar; 19(5):1455-61.
33. Du XL, Key CR, Dickie L, et al. External validation of medicare claims for breast cancer chemotherapy compared with medical chart reviews. Med Care. 2006 Feb; 44(2):124-31.
34. National Cancer Institute. SEER-Medicare: calculation of comorbidity weights. Bethesda, MD: National Cancer Institute, 2009. Available at: http://healthservices.cancer.gov/seermedicare/program/comorbidity.html.
35. Klabunde CN, Potosky AL, Legler JM, et al. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000 Dec; 53(12):1258-67.
36. Du XL, Chan W, Giordano S, et al. Variation in modes of chemotherapy administration for breast carcinoma and association with hospitalization for chemotherapy-related toxicity. Cancer. 2005 Sep; 104(5):913-24.
37. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40 (5):373-83.
38. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992 Jun; 45(6):613-9.
39. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: difering perspectives. J Clin Epidemiol. 1993 Oct; 46(10):1075-9.
40. Allison PD. Survival analysis using the SAS system: a practical guide. Cary, NC: SAS Institute Inc., 1995.
41. Office of Disease Prevention and Health Promotion, U. S. Department of Health and Human Services. Healthy People 2010. Washington, DC: Office of Disease Prevention and Health Promotion, U. S. Department of Health and Human Services, 2010. Available at: http://www.healthypeople.gov/about/hpfact.htm.
42. Mandelblatt JS, Kerner JF, Hadley J, et al. Variations in breast carcinoma treatment in older medicare beneficiaries: is it black or white. Cancer. 2002 Oct; 95(7):1401-14.
43. Wilkinson AV, Vasdevan V, Honn SE, et al. Sociodemographic characteristics, health beliefs, and the accuracy of cancer knowledge. J Cancer Educ. 2009;24 (1):58-64.